Cellulitis and erysipelas - Symptoms, Causes, Images, and Treatment Options

Diseases

Highlights & Basics

Key Highlights

Cellulitis and erysipelas can usually be diagnosed based on history and examination only, although blood cultures and microscopic examination of cutaneous aspirates, biopsies, or swabs should be considered for selected patients, including those who are immunocompromised.
Prior episodes, preexisting lymphedema or venous insufficiency, diabetes, obesity, and tinea pedis can all predispose to cellulitis.
Antibiotics targeted at the most common etiologies (streptococci and Staphylococcus aureus) usually result in resolution.

Quick Reference

History & Exam
- Key Factors
- Other Factors
More information...
Diagnostics Tests
More information...
Treatment Options
More information...

Definition

Epidemiology

Etiology

Pathophysiology

Citations

Key Articles

Raff AB, Kroshinsky D. Cellulitis: a review. JAMA. 2016 Jul 19;316(3):325-37.[Abstract]
Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis. 2014 Jul 15;59(2):e10-52.[Abstract][Full Text]
American College of Radiology. ACR appropriateness criteria: suspected osteomyelitis, septic arthritis, or soft tissue infection (excluding spine and diabetic foot). 2022 [internet publication].[Full Text]

Referenced Articles

1. Gunderson CG. Cellulitis: definition, etiology, and clinical features. Am J Med. 2011 Dec;124(12):1113-22.[Abstract]
2. Sartelli M, Coccolini F, Kluger Y, et al. WSES/GAIS/WSIS/SIS-E/AAST global clinical pathways for patients with skin and soft tissue infections. World J Emerg Surg. 2022 Jan 15;17(1):3.[Abstract][Full Text]
3. Institute For Health Metrics and Evaluation. Global health metrics: cellulitis - level 4 cause. 2021 [internet publication].[Full Text]
4. Mcnamara DR, Tleyjeh IM, Berbari EF, et al. Incidence of lower-extremity cellulitis: a population-based study in Olmsted County, Minnesota. Mayo Clin Proc. 2007 Jul;82(7):817-21.[Abstract]
5. Kumar M, Jong Ngian VJ, Yeong C, et al. Cellulitis in older people over 75 years - are there differences? Ann Med Surg (Lond). 2020 Jan;49:37-40.[Abstract][Full Text]
6. Peterson RA, Polgreen LA, Cavanaugh JE, et al. Increasing incidence, cost, and seasonality in patients hospitalized for cellulitis. Open Forum Infect Dis. 2017 Winter;4(1):ofx008.[Abstract][Full Text]
7. Hsu RJ, Chou CC, Liu JM, et al. The association of cellulitis incidence and meteorological factors in Taiwan. Epidemiol Infect. 2019 Jan;147:e138.[Abstract][Full Text]
8. Manning L, Cannon J, Dyer J, et al. Seasonal and regional patterns of lower leg cellulitis in Western Australia. Intern Med J. 2019 Feb;49(2):212-6.[Abstract][Full Text]
9. Kaye KS, Petty LA, Shorr AF, et al. Current epidemiology, etiology, and burden of acute skin infections in the United States. Clin Infect Dis. 2019 Apr 8;68(suppl 3):S193-9.[Abstract][Full Text]
10. Pallin DJ, Egan DJ, Pelletier AJ, et al. Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus. Ann Emerg Med. 2008 Mar;51(3):291-8. [Abstract]
11. Qualls ML, Mooney MM, Camargo CA Jr, et al. Emergency department visit rates for abscess versus other skin infections during the emergence of community-associated methicillin-resistant Staphylococcus aureus, 1997-2007. Clin Infect Dis. 2012 Jul;55(1):103-5.[Abstract][Full Text]
12. Raff AB, Kroshinsky D. Cellulitis: a review. JAMA. 2016 Jul 19;316(3):325-37.[Abstract]
13. Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis. 2014 Jul 15;59(2):e10-52.[Abstract][Full Text]
14. Dalal A, Eskin-Schwartz M, Mimouni D, et al. Interventions for the prevention of recurrent erysipelas and cellulitis. Cochrane Database Syst Rev. 2017 Jun 20;(6):CD009758. [Abstract][Full Text]
15. Jeng A, Beheshti M, Li J, et al. The role of beta-hemolytic streptococci in causing diffuse, nonculturable cellulitis: a prospective investigation. Medicine (Baltimore). 2010 Jul;89(4):217-26. [Abstract]
16. Ki V, Rotstein C. Bacterial skin and soft tissue infections in adults: A review of their epidemiology, pathogenesis, diagnosis, treatment and site of care. Can J Infect Dis Med Microbiol. 2008 Mar;19(2):173-84.[Abstract][Full Text]
17. Kupper TS. Immune and inflammatory processes in cutaneous tissues. Mechanisms and speculations. J Clin Invest. 1990 Dec;86(6):1783-9.[Abstract][Full Text]
18. Okada N, Pentland AP, Falk P, et al. M Protein and protein F act as important determinants of cell-specific tropism of Streptococcus pyogenes in skin tissue. J Clin Invest. 1994 Sep;94(3):965-77.[Abstract][Full Text]
19. Semel JD, Goldin H. Association of athlete's foot with cellulitis of the lower extremities: diagnostic value of bacterial cultures of ipsilateral interdigital space samples. Clin Infect Dis. 1996 Nov;23(5):1162-4.[Abstract]
20. National Institute for Health and Care Excellence. Cellulitis and erysipelas: antimicrobial prescribing. Sep 2019 [internet publication].[Full Text]
21. Bjornsdottir S, Gottfredsson M, Thorisdottir AS, et al. Risk factors for acute cellulitis of the lower limb: a prospective case-control study. Clin Infect Dis. 2005 Nov 15;41(10):1416-22.[Abstract][Full Text]
22. Karakaş M, Baba M, Aksungur VL, et al. Manifestation of cellulitis after saphenous venectomy for coronary bypass surgery. J Eur Acad Dermatol Venereol. 2002 Sep;16(5):438-40.[Abstract]
23. Quirke M, Ayoub F, McCabe A, et al. Risk factors for nonpurulent leg cellulitis: a systematic review and meta-analysis. Br J Dermatol. 2017 Aug;177(2):382-94.[Abstract]
24. McNamara DR, Tleyjeh IM, Berbari EF, et al. A predictive model of recurrent lower extremity cellulitis in a population-based cohort. Arch Intern Med. 2007 Apr 9;167(7):709-15.[Abstract][Full Text]
25. Simon MS, Cody RL. Cellulitis after axillary lymph node dissection for carcinoma of the breast. Am J Med. 1992 Nov;93(5):543-8.[Abstract]
26. Dankert J, Bouma J. Recurrent acute leg cellulitis after hysterectomy with pelvic lymphadenectomy. Br J Obstet Gynaecol. 1987 Aug;94(8):788-90.[Abstract]
27. Woo PC, Lum PN, Wong SS, et al. Cellulitis complicating lymphedema. Eur J Clin Microbiol Infect Dis. 2000 Apr;19(4):294-7.[Abstract]
28. Edwards G, Freeman K, Llewelyn MJ, et al. What diagnostic strategies can help differentiate cellulitis from other causes of red legs in primary care? BMJ. 2020 Feb 12;368:m54.[Abstract]
29. Chambers HF. Skin and soft tissue infections in persons who inject drugs. Infect Dis Clin North Am. 2021 Mar;35(1):169-81.[Abstract]
30. Taira KG, Wang M, Guo W, et al. Association of cellulitis with obesity: systematic review and meta-analysis. JMIR Dermatol. 2024 Aug 20;7:e54302.[Abstract][Full Text]
31. Stahlman S, Williams VF, Oh GT, et al. Skin and soft tissue infections, active component, U.S. Armed Forces, January 2016-September 2020. MSMR. 2021 Apr;28(4):27-38.[Abstract][Full Text]
32. Johnson RC, Ellis MW, Schlett CD, et al. Bacterial etiology and risk factors associated with cellulitis and purulent skin abscesses in military trainees. PLoS One. 2016;11(10):e0165491.[Abstract][Full Text]
33. Weng QY, Raff AB, Cohen JM, et al. Costs and consequences associated with misdiagnosed lower extremity cellulitis. JAMA Dermatol. 2017 Feb 1;153(2):141-6.[Abstract]
34. Boettler MA, Kaffenberger BH, Chung CG. Cellulitis: a review of current practice guidelines and differentiation from pseudocellulitis. Am J Clin Dermatol. 2022 Mar;23(2):153-65.[Abstract]
35. Cutler TS, Jannat-Khah DP, Kam B, et al. Prevalence of misdiagnosis of cellulitis: a systematic review and meta-analysis. J Hosp Med. 2023 Mar;18(3):254-61.[Abstract]
36. Pulia MS, Schwei RJ, Alexandridis R, et al. Validation of thermal imaging and the ALT-70 prediction model to differentiate cellulitis from pseudocellulitis. JAMA Dermatol. 2024 May 1;160(5):511-7.[Abstract]
37. Li DG, Mostaghimi A. The quest for a more accurate diagnosis of cellulitis: in dreams begin responsibilities. JAMA Dermatol. 2024 May 1;160(5):489-91.[Abstract]
38. Ko LN, Garza-Mayers AC, St John J, et al. Effect of dermatology consultation on outcomes for patients with presumed cellulitis: a randomized clinical trial. JAMA Dermatol. 2018 May 1;154(5):529-36.[Abstract][Full Text]
39. Daum RS. Skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus. N Engl J Med. 2007 Jul 26;357(4):380-90. [Dosage error in text; published correction appears in N Engl J Med. 2007;357:1357.][Abstract]
40. Jackson KA, Bohm MK, Brooks JT, et al. Invasive methicillin-resistant staphylococcus aureus infections among persons who inject drugs - six sites, 2005-2016. MMWR Morb Mortal Wkly Rep. 2018 Jun 8;67(22):625-8.[Abstract][Full Text]
41. Clinical Resource Efficiency Support Team (CREST). Guidelines on the management of cellulitis in adults. Jun 2005 [internet publication].[Full Text]
42. Phoenix G, Das S, Joshi M. Diagnosis and management of cellulitis. BMJ. 2012 Aug 7;345:e4955.[Abstract]
43. Morris AD. Cellulitis and erysipelas. BMJ Clin Evid. 2008 Jan 2;2008:1708.[Abstract]
44. Stevens DL, Bryant AE. Streptococcus pyogenes impetigo, erysipelas, and cellulitis. 2nd ed.Oklahoma: University of Oklahoma Health Sciences Center; 2022. [Full Text]
45. Centers for Disease Control and Prevention. Group a strep infection: clinical guidance for group a streptococcal cellulitis. Mar 2020 [internet publication]
46. Sakamoto S, Oiso N, Emoto M, et al. Cellulitis with leukocytopenia as an initial sign of acute promyelocytic leukemia. Case Rep Dermatol. 2012 Jan;4(1):47-9.[Abstract][Full Text]
47. Moran GJ, Krishnadasan A, Gorwitz RJ, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. New Engl J Med. 2006 Aug 17;355(7):666-74.[Abstract][Full Text]
48. May LS, Rothman RE, Miller LG, et al. A randomized clinical trial comparing use of rapid molecular testing for Staphylococcus aureus for patients with cutaneous abscesses in the emergency department with standard of care. Infect Control Hosp Epidemiol. 2015 Dec;36(12):1423-30. [Abstract][Full Text]
49. Toleman MS, Vipond IB, Brindle R. Specific PCR, bacterial culture, serology and pharyngeal sampling to enhance the aetiological diagnosis of cellulitis. J Med Microbiol. 2016 Jan;65(1):44-7.[Abstract]
50. Bailey E, Kroshinsky D. Cellulitis: diagnosis and management. Dermatol Ther. 2011 Mar-Apr;24(2):229-39.[Abstract]
51. Public Health England. UK standards for microbiology investigations: investigation of swabs from skin and superficial soft tissue infections. December 2018 [internet publication].[Full Text]
52. Miller JM, Binnicker MJ, Campbell S, et al. Guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2024 update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM). Clin Infect Dis. 5 Mar 2024 [Epub ahead of print].[Abstract][Full Text]
53. Simundic AM, Bölenius K, Cadamuro J, et al. Joint EFLM-COLABIOCLI recommendation for venous blood sampling. Clin Chem Lab Med. 2018;56(12):2015-38.[Abstract]
54. American College of Radiology. ACR appropriateness criteria: suspected osteomyelitis, septic arthritis, or soft tissue infection (excluding spine and diabetic foot). 2022 [internet publication].[Full Text]
55. Subramaniam S, Bober J, Chao J, et al. Point-of-care ultrasound for diagnosis of abscess in skin and soft tissue infections. Acad Emerg Med. 2016 Nov;23(11):1298-306. [Abstract]
56. Gottlieb M, Avila J, Chottiner M, et al. Point-of-care ultrasonography for the diagnosis of skin and soft tissue abscesses: a systematic review and meta-analysis. Ann Emerg Med. 2020 Jul;76(1):67-77.[Abstract]
57. Muhammad R, Kyari F. Preseptal and orbital cellulitis: how to identify and treat these conditions - and save lives. Community Eye Health. 2024;36(121):13-14.[Abstract][Full Text]
58. Ali SZ, Srinivasan S, Peh WC. MRI in necrotizing fasciitis of the extremities. Br J Radiol. 2014 Jan;87(1033):20130560.[Abstract][Full Text]
59. Joshi A, Alomar T, Kaune DF, et al. A case of necrotizing fasciitis initially misdiagnosed as cellulitis. Int J Surg Case Rep. 2024 May;118:109701.[Abstract][Full Text]
60. Chen LL, Fasolka B, Treacy C. Necrotizing fasciitis: a comprehensive review. Nursing. 2020 Sep;50(9):34-40.[Abstract][Full Text]
61. Schmid MR, Kossmann T, Duewell S. Differentiation of necrotizing fasciitis and cellulitis using MR imaging. Am J Roentgenol. 1998 Mar;170(3):615-20.[Abstract][Full Text]
62. McHenry CR, Piotrowski JJ, Petrinic D. Determinants of mortality for necrotizing soft-tissue infections. Ann Surg. 1995 May;221(5):558-63[Abstract][Full Text]
63. Keller EC, Tomecki KJ, Alraies MC. Distinguishing cellulitis from its mimics. Cleve Clin J Med. 2012 Aug;79(8):547-52.[Abstract][Full Text]
64. Goss JA, Greene AK. Sensitivity and specificity of the stemmer sign for lymphedema: a clinicallymphoscintigraphic study. Plast Reconstr Surg Glob Open. 2019 Jun;7(6):e2295.[Abstract][Full Text]
65. Stolldorf DP, Dietrich MS, Ridner SH. Symptom frequency, intensity, and distress in patients with lower limb lymphedema. Lymphat Res Biol. 2016 Jun;14(2):78-87.[Abstract][Full Text]
66. Greene AK, Goss JA. Diagnosis and staging of lymphedema. Semin Plast Surg. 2018 Feb;32(1):12-16.[Abstract][Full Text]
67. Lantos PM, Rumbaugh J, Bockenstedt LK, et al. Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 guidelines for the prevention, diagnosis and treatment of lyme disease. Clin Infect Dis. 2021 Jan 23;72(1):e1-48.[Abstract][Full Text]
68. Lantos PM, Rumbaugh J, Bockenstedt LK, et al. Clinical practice guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 guidelines for the prevention, diagnosis, and treatment of Lyme disease. Arthritis Care Res (Hoboken). 2021 Oct;73(1):1-9.[Full Text]
69. National Institute for Health and Care Excellence. Lyme disease. October 2018 [internet publication].[Full Text]
70. Falagas ME, Vergidis PI. Narrative review: diseases that masquerade as infectious cellulitis. Ann Intern Med. 2005 Jan 4;142(1):47-55.[Abstract]
71. Fitzpatrick TB, Johnson RA, Wolff K. Color atlas & synopsis of clinical dermatology: common and serious diseases. 4th ed. New York, NY: The McGraw-Hill Companies; 2001.
72. Pérez-Garza DM, Chavez-Alvarez S, Ocampo-Candiani J, et al. Erythema nodosum: a practical approach and diagnostic algorithm. Am J Clin Dermatol. 2021 May;22(3):367-78.[Abstract][Full Text]
73. Maronese CA, Pimentel MA, Li MM, et al. Pyoderma gangrenosum: an updated literature review on established and emerging pharmacological treatments. Am J Clin Dermatol. 2022 Sep;23(5):615-34.[Abstract][Full Text]
74. Barbe M, Batra A, Golding S, et al. Pyoderma gangrenosum: a literature review. Clin Podiatr Med Surg. 2021 Oct;38(4):577-88.[Abstract]
75. Aberer W, Konrad K, Wolff K. Wells' syndrome is a distinctive disease entity and not a histologic diagnosis. J Am Acad Dermatol. 1988 Jan;18(1 Pt 1):105-14.[Abstract]
76. Callen JP. Neutrophilic dermatoses. Dermatol Clin. 2002 Jul;20(3):409-19.[Abstract]
77. Rapini RP, Warner NB. Relapsing polychondritis. Clin Dermatol. 2006 Nov-Dec;24(6):482-5.[Abstract]
78. Fine A, Zacharias J. Calciphylaxis is usually non-ulcerating: risk factors, outcome and therapy. Kidney Int. 2002 Jun;61(6):2210-7.[Abstract][Full Text]
79. Kirsner RS, Pardes JB, Eaglstein WH, et al. The clinical spectrum of lipodermatosclerosis. J Am Acad Dermatol. 1993 Apr;28(4):623-7.[Abstract]
80. Eron LJ, Lipsky BA, Low DE, et al. Managing skin and soft tissue infections: expert panel recommendations on key decision points. J Antimicrob Chemother. 2003 Nov;52 Suppl 1:i3-17.[Abstract]
81. Brindle R, Williams OM, Barton E, et al. Assessment of antibiotic treatment of cellulitis and erysipelas: a systematic review and meta-analysis. JAMA Dermatol. 2019 Jun 12;155(9):1033-40.[Abstract][Full Text]
82. Mistry K, Sharma S, Patel M, et al. Clinical response to antibiotic regimens in lower limb cellulitis: a systematic review. Clin Exp Dermatol. 2021 Jan;46(1):42-9.[Abstract][Full Text]
83. Shu Z, Cao J, Li H, et al. Efficacy and safety of first- and second-line antibiotics for cellulitis and erysipelas: a network meta-analysis of randomized controlled trials. Arch Dermatol Res. 2024 Sep 6;316(8):603.[Abstract][Full Text]
84. Leekha S, Terrell CL, Edson RS. General principles of antimicrobial therapy. Mayo Clin Proc. 2011 Feb;86(2):156-67.[Abstract][Full Text]
85. Leong HN, Kurup A, Tan MY, et al. Management of complicated skin and soft tissue infections with a special focus on the role of newer antibiotics. Infect Drug Resist. 2018;11:1959-74.[Abstract][Full Text]
86. Swartz MN. Clinical practice: cellulitis. N Engl J Med. 2004 Feb 26;350(9):904-12.[Abstract]
87. Sartelli M, Guirao X, Hardcastle TC, et al. 2018 WSES/SIS-E consensus conference: recommendations for the management of skin and soft-tissue infections. World J Emerg Surg. 2018;13:58.[Abstract][Full Text]
88. Lee RA, Centor RM, Humphrey LL, et al. Appropriate use of short-course antibiotics in common infections: best practice advice from the American College of Physicians. Ann Intern Med. 2021 Jun;174(6):822-7.[Abstract][Full Text]
89. Hamill L, Keijzers G, Robertson S, et al. Anti-inflammatories as adjunct treatment for cellulitis: a systematic review and meta-analysis. CJEM. 2024 Jul;26(7):472-81.[Abstract]
90. Sharkey AR, King SW, Ramsden AJ, et al. Do surgical interventions for limb lymphoedema reduce cellulitis attack frequency? Microsurgery. 2017 May;37(4):348-53. [Abstract]
91. Webb E, Neeman T, Bowden FJ, et al. Compression Therapy to Prevent Recurrent Cellulitis of the Leg. N Engl J Med. 2020 Aug 13;383(7):630-639.[Abstract]
92. Webster J, Osborne S, Rickard CM, et al. Clinically-indicated replacement versus routine replacement of peripheral venous catheters. Cochrane Database Syst Rev. 2019 Jan 23;(1):CD007798.[Abstract][Full Text]
93. Tami A, Othman S, Sudhakar A, et al. Ludwig's angina and steroid use: a narrative review. Am J Otolaryngol. 2020 May-Jun;41(3):102411.[Abstract]
94. Bergkvist PI, Sjöbeck K. Antibiotic and prednisolone therapy of erysipelas: a randomized, double blind, placebo-controlled study. Scand J Infect Dis. 1997;29(4):377-82.[Abstract]